Financial Times Examines Pharma's Growing Interest in India
January 27, 2011
"International pharmaceutical companies once looked with frustration at Indian drug makers, which were notorious for churning out low-cost, copycat versions of patented drugs and selling them to developing countries. More recently, they have been looking at Indias fast growing pharmaceutical industry in a different light -- as an increasingly integral part of the global supply chain in an environment of intensifying pressure on prices," the Financial Times writes. The article, which documents the rise of foreign-owned companies in India's domestic drug market, notes, "Recent takeovers have raised concerns among some policymakers that foreign ownership may lead to sharply higher domestic drug prices, potentially a big problem in a country where 80 per cent of total healthcare costs are shouldered privately" (Kazmin, 1/26).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)